» Articles » PMID: 37223599

Ocular Manifestations of Spondyloarthritis

Overview
Specialty Rheumatology
Date 2023 May 24
PMID 37223599
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Ocular manifestations are seen in several autoimmune disorders including spondyloarthritis (SpAs). Though acute anterior uveitis (AAU) is the hallmark of SpAs, episcleritis and scleritis are also seen. Genetic and geographical factors impact the prevalence of AAU; however, available evidence support that HLA-B27 positivity is closely associated with it.

Objective: The current narrative review is focused on clinical features of AAU and its management.

Methods: For the purpose of this narrative review; literature search covered MEDLINE, Google scholar and EMBASE databases and included articles published in English language from January 1980 till April 2022 using the following keywords: "Ankylosing spondylitis", "Spondyloarthritis", "Eye manifestations", "Ocular", "Uveitis" and "Arthritis".

Conclusion: Patients with SpA may suffer from different ocular complications with uveitis being the most common one. Biological therapy is a promising medical strategy enabling in achieving therapeutic goals with minimal adverse effects. An effective management strategy for patients with AAU associated with SpA could be formulated by the collaboration between ophthalmologists and rheumatologists.

Citing Articles

Treatment of recurrent uveitis and ankylosing spondylitis with Golimumab: a case report, Letter to Editor.

Kudsi M, Drie T, Dumirieh S Ann Med Surg (Lond). 2024; 86(8):4932-4934.

PMID: 39118711 PMC: 11305809. DOI: 10.1097/MS9.0000000000002342.


Time Trend Analysis of Comorbidities in Ankylosing Spondylitis: A Population-Based Study from 53,142 Hospitalizations in Poland.

Helon K, Wislowska M, Kanecki K, Gorynski P, Nitsch-Osuch A, Bonek K J Clin Med. 2024; 13(2).

PMID: 38276108 PMC: 10816889. DOI: 10.3390/jcm13020602.


Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study.

Kougkas N, Magiouf K, Gialouri C, Evangelatos G, Pappa M, Dimouli A Rheumatol Int. 2023; 43(11):2081-2088.

PMID: 37610650 PMC: 10495278. DOI: 10.1007/s00296-023-05424-0.

References
1.
Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M . Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis. 2006; 65(12):1631-4. PMC: 1798480. DOI: 10.1136/ard.2006.052092. View

2.
Munoz-Fernandez S, Martin-Mola E . Uveitis. Best Pract Res Clin Rheumatol. 2006; 20(3):487-505. DOI: 10.1016/j.berh.2006.03.008. View

3.
Power W, Rodriguez A, Pedroza-Seres M, Foster C . Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998; 105(9):1646-51. DOI: 10.1016/S0161-6420(98)99033-9. View

4.
Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J . The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68(6):777-83. DOI: 10.1136/ard.2009.108233. View

5.
Burgos-Varga R, Cheng-Chung Wei J, Rahman M, Akkoc N, Haq S, Hammoudeh M . The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study. Arthritis Res Ther. 2016; 18(1):132. PMC: 4896040. DOI: 10.1186/s13075-016-1027-9. View